CROI CROI 2014 - CROI 2014: Oral Abstract Sessions CROI 2014 - CROI 2014: Oral Abstract Sessions http://www.croiconference.org/ en-us Copyright 2014, CROI. All Rights Reserved. Podcasts support@capitalreach.com > CROI http://www.croiwebcasts.org/console/player/22042.mp3?mediaType=feedmp3 "Longitudinal Phenotypic Profiling of Early HCV-Specific CD4 T Cells in HIV- and HIV+ Individuals" by Diana Y. Chen of Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States http://www.croiwebcasts.org/console/player/22042.mp3 Oral Abstract: Hepatitis "Longitudinal Phenotypic Profiling of Early HCV-Specific CD4 T Cells in HIV- and HIV+ Individuals" by Diana Y. Chen of Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22043.mp3?mediaType=feedmp3 "Rapid Peripheral In Vivo Cellular Changes During Interferon-Free Treatment of Hepatitis C" by Eric G. Meissner of Laboratory of Immunoregulation, NIAID/NIH, Bethesda, MD, United States http://www.croiwebcasts.org/console/player/22043.mp3 Oral Abstract: Hepatitis "Rapid Peripheral In Vivo Cellular Changes During Interferon-Free Treatment of Hepatitis C" by Eric G. Meissner of Laboratory of Immunoregulation, NIAID/NIH, Bethesda, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22044.mp3?mediaType=feedmp3 "Faldaprevir Plus Pegylated Interferon Alfa-2a/Ribavirin in HIV/HCV Coinfection: STARTVerso4" by Douglas Dieterich of Mount Sinai Medical Center, New York, NY, United States http://www.croiwebcasts.org/console/player/22044.mp3 Oral Abstract: Hepatitis "Faldaprevir Plus Pegylated Interferon Alfa-2a/Ribavirin in HIV/HCV Coinfection: STARTVerso4" by Douglas Dieterich of Mount Sinai Medical Center, New York, NY, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22045.mp3?mediaType=feedmp3 "Simeprevir (TMC435) Plus PegIFN/Ribavirin in HCV Genotype-1/HIV-1 Coinfection (Study C212)" by Douglas Dieterich of Icahn School of Medicine at Mount Sinai, New York, NY, United States http://www.croiwebcasts.org/console/player/22045.mp3 Oral Abstract: Hepatitis "Simeprevir (TMC435) Plus PegIFN/Ribavirin in HCV Genotype-1/HIV-1 Coinfection (Study C212)" by Douglas Dieterich of Icahn School of Medicine at Mount Sinai, New York, NY, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22046.mp3?mediaType=feedmp3 "All-Oral Combination of Daclatasvir, Asunaprevir, and BMS-791325 for HCV Genotype 1 Infection" by Trevor Hawkins of Southwest CARE Center, Santa Fe, NM, United States http://www.croiwebcasts.org/console/player/22046.mp3 Oral Abstract: Hepatitis "All-Oral Combination of Daclatasvir, Asunaprevir, and BMS-791325 for HCV Genotype 1 Infection" by Trevor Hawkins of Southwest CARE Center, Santa Fe, NM, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22047.mp3?mediaType=feedmp3 "Sofosbuvir Plus Ribavirin for HCV Genotype 1-3 Infection in HIV Coinfected Patients (PHOTON-1)" by Susanna Naggie of Duke Clinical Research Institute, Durham, NC, United States http://www.croiwebcasts.org/console/player/22047.mp3 Oral Abstract: Hepatitis "Sofosbuvir Plus Ribavirin for HCV Genotype 1-3 Infection in HIV Coinfected Patients (PHOTON-1)" by Susanna Naggie of Duke Clinical Research Institute, Durham, NC, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22048.mp3?mediaType=feedmp3 "Combination Oral, Hepatitis C Antiviral Therapy for 6 or 12 Weeks: Final Results of the SYNERGY Trial" by Anita Kohli of Critical Care Medicine Department, National Institutes of Health, Bethesda, MD, United States and Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc. (formerly SAIC–Frederick, Inc.), Frederick National Laboratory for Cancer Research, Frederick, MD, United States http://www.croiwebcasts.org/console/player/22048.mp3 Oral Abstract: Hepatitis "Combination Oral, Hepatitis C Antiviral Therapy for 6 or 12 Weeks: Final Results of the SYNERGY Trial" by Anita Kohli of Critical Care Medicine Department, National Institutes of Health, Bethesda, MD, United States and Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc. (formerly SAIC–Frederick, Inc.), Frederick National Laboratory for Cancer Research, Frederick, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22049.mp3?mediaType=feedmp3 "Daclatasvir in Combination With Simeprevir ± Ribavirin for Hepatitis C Virus Genotype 1 Infection" by Christophe Hezode of Hôpital Henri Mondor, Paris, France http://www.croiwebcasts.org/console/player/22049.mp3 Oral Abstract: Hepatitis "Daclatasvir in Combination With Simeprevir ± Ribavirin for Hepatitis C Virus Genotype 1 Infection" by Christophe Hezode of Hôpital Henri Mondor, Paris, France 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22050.mp3?mediaType=feedmp3 "PEARL III: SVR ≥99% After 12 Wks of ABT-450/r/267 + ABT-333 ± RBV in Treatment Naïve HCV GT1b Infection" by K Rajender Reddy of University of Pennsylvania, Philadelphia, PA, United States http://www.croiwebcasts.org/console/player/22050.mp3 Oral Abstract: Hepatitis "PEARL III: SVR ≥99% After 12 Wks of ABT-450/r/267 + ABT-333 ± RBV in Treatment Naïve HCV GT1b Infection" by K Rajender Reddy of University of Pennsylvania, Philadelphia, PA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22053.mp3?mediaType=feedmp3 "Moderator" by Victor G. Valcour of University of California San Francisco, San Francisco, CA, United States http://www.croiwebcasts.org/console/player/22053.mp3 Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis "Moderator" by Victor G. Valcour of University of California San Francisco, San Francisco, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22054.mp3?mediaType=feedmp3 "Early Antiretroviral Therapy Appears To Normalize Intrathecal Markers of Immune Activation" by Julia Peterson of Neurology, University of California San Francisco, San Francisco, CA, United States http://www.croiwebcasts.org/console/player/22054.mp3 Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis "Early Antiretroviral Therapy Appears To Normalize Intrathecal Markers of Immune Activation" by Julia Peterson of Neurology, University of California San Francisco, San Francisco, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22055.mp3?mediaType=feedmp3 "Immediate Antiretroviral Therapy Mitigates the Development of Neuronal Injury in Acute HIV" by Michael J. Peluso of Department of Medicine, Brigham and Women’s Hospital, Boston, MA, United States http://www.croiwebcasts.org/console/player/22055.mp3 Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis "Immediate Antiretroviral Therapy Mitigates the Development of Neuronal Injury in Acute HIV" by Michael J. Peluso of Department of Medicine, Brigham and Women’s Hospital, Boston, MA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22056.mp3?mediaType=feedmp3 "Replication of HIV-1 in the Central Nervous System of Adults Early After Infection" by Christa Buckheit Sturdevant of UNC Chapel Hill, Chapel Hill, NC, United States http://www.croiwebcasts.org/console/player/22056.mp3 Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis "Replication of HIV-1 in the Central Nervous System of Adults Early After Infection" by Christa Buckheit Sturdevant of UNC Chapel Hill, Chapel Hill, NC, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22057.mp3?mediaType=feedmp3 "Persistent CSF, But Not Plasma HIV RNA Is Associated With Increased Risk of New-Onset Depression" by Edward R. Hammond of The Johns Hopkins University, Baltimore, MD, United States http://www.croiwebcasts.org/console/player/22057.mp3 Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis "Persistent CSF, But Not Plasma HIV RNA Is Associated With Increased Risk of New-Onset Depression" by Edward R. Hammond of The Johns Hopkins University, Baltimore, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22058.mp3?mediaType=feedmp3 "CSF Metabolomics Reveals Altered Waste Clearance and Accelerated Aging in HIV Patients With HAND" by Edana Cassol of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, United States http://www.croiwebcasts.org/console/player/22058.mp3 Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis "CSF Metabolomics Reveals Altered Waste Clearance and Accelerated Aging in HIV Patients With HAND" by Edana Cassol of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22059.mp3?mediaType=feedmp3 "Cerebral Small Vessel Disease and HAND in ARV-Treated Subjects" by Ronald J. Ellis of University of California San Diego, San Diego, CA, United States http://www.croiwebcasts.org/console/player/22059.mp3 Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis "Cerebral Small Vessel Disease and HAND in ARV-Treated Subjects" by Ronald J. Ellis of University of California San Diego, San Diego, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22063.mp3?mediaType=feedmp3 "Temporal Trends in Prognostic Markers of HIV-1 Virulence and Transmissibility" by Nikos Pantazis of Hygiene, Epidemiology & Medical Statistics, Athens University Medical School, Athens, Greece http://www.croiwebcasts.org/console/player/22063.mp3 Oral Abstract: Prevention and Epidemiology: Evolving Trends "Temporal Trends in Prognostic Markers of HIV-1 Virulence and Transmissibility" by Nikos Pantazis of Hygiene, Epidemiology & Medical Statistics, Athens University Medical School, Athens, Greece 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22064.mp3?mediaType=feedmp3 "Transmission Clusters, Recent Infection and STIs Among New HIV Cases: Implications for Prevention" by Hong-Ha M. Truong of University of California San Francisco, San Francisco, CA, United States and Gladstone Institute of Virology and Immunology, San Francisco, CA, United States http://www.croiwebcasts.org/console/player/22064.mp3 Oral Abstract: Prevention and Epidemiology: Evolving Trends "Transmission Clusters, Recent Infection and STIs Among New HIV Cases: Implications for Prevention" by Hong-Ha M. Truong of University of California San Francisco, San Francisco, CA, United States and Gladstone Institute of Virology and Immunology, San Francisco, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22065.mp3?mediaType=feedmp3 "Race and Age Disparities in HIV Incidence and Prevalence Among MSM in Atlanta, GA" by Eli S. Rosenberg of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, United States http://www.croiwebcasts.org/console/player/22065.mp3 Oral Abstract: Prevention and Epidemiology: Evolving Trends "Race and Age Disparities in HIV Incidence and Prevalence Among MSM in Atlanta, GA" by Eli S. Rosenberg of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22066.mp3?mediaType=feedmp3 "Correlating GSK1265744 Plasma Levels To Prevention of Rectal SHIV Transmission in Macaques" by Chasity D. Andrews of Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY, United States http://www.croiwebcasts.org/console/player/22066.mp3 Oral Abstract: Prevention and Epidemiology: Evolving Trends "Correlating GSK1265744 Plasma Levels To Prevention of Rectal SHIV Transmission in Macaques" by Chasity D. Andrews of Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22067.mp3?mediaType=feedmp3 "Monthly GSK744 Long-Acting Injections Protect Macaques Against Repeated Vaginal SHIV Exposures" by J. Gerardo Garcia-Lerma of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States http://www.croiwebcasts.org/console/player/22067.mp3 Oral Abstract: Prevention and Epidemiology: Evolving Trends "Monthly GSK744 Long-Acting Injections Protect Macaques Against Repeated Vaginal SHIV Exposures" by J. Gerardo Garcia-Lerma of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22068.mp3?mediaType=feedmp3 "Safety and Pharmacokinetics/Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings" by Beatrice A. Chen of University of Pittsburgh, Pittsburgh, PA, United States http://www.croiwebcasts.org/console/player/22068.mp3 Oral Abstract: Prevention and Epidemiology: Evolving Trends "Safety and Pharmacokinetics/Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings" by Beatrice A. Chen of University of Pittsburgh, Pittsburgh, PA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22069.mp3?mediaType=feedmp3 "FAME-02: A Phase I Trial To Assess Safety, PK, and PD of Gel and Film Formulations of Dapivirine" by Katherine E. Bunge of Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, United States http://www.croiwebcasts.org/console/player/22069.mp3 Oral Abstract: Prevention and Epidemiology: Evolving Trends "FAME-02: A Phase I Trial To Assess Safety, PK, and PD of Gel and Film Formulations of Dapivirine" by Katherine E. Bunge of Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22070.mp3?mediaType=feedmp3 "Single-Agent TDF Versus Combination FTC/TDF PrEP Among Heterosexual Men and Women" by Jared Baeten of University of Washington, Seattle, WA, United States http://www.croiwebcasts.org/console/player/22070.mp3 Oral Abstract: Prevention and Epidemiology: Evolving Trends "Single-Agent TDF Versus Combination FTC/TDF PrEP Among Heterosexual Men and Women" by Jared Baeten of University of Washington, Seattle, WA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22071.mp3?mediaType=feedmp3 "Divergent Adherence Estimates With Pharmacokinetic and Behavioral Measures in VOICE (MTN003)" by Ariane van der Straten of Women’s Global Health Imperative, RTI International, San Francisco, CA, United States and Department of Medicine, Center for AIDS Prevention Studies (CAPS), University of California San Francisco, San Francisco, CA, United States http://www.croiwebcasts.org/console/player/22071.mp3 Oral Abstract: Prevention and Epidemiology: Evolving Trends "Divergent Adherence Estimates With Pharmacokinetic and Behavioral Measures in VOICE (MTN003)" by Ariane van der Straten of Women’s Global Health Imperative, RTI International, San Francisco, CA, United States and Department of Medicine, Center for AIDS Prevention Studies (CAPS), University of California San Francisco, San Francisco, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22072.mp3?mediaType=feedmp3 "HIV Transmission Risk Through Condomless Sex If HIV+ Partner On Suppressive ART: PARTNER Study" by Alison Rodger of Research Department of Infection & Population Health, University College London, London, United Kingdom http://www.croiwebcasts.org/console/player/22072.mp3 Oral Abstract: Prevention and Epidemiology: Evolving Trends "HIV Transmission Risk Through Condomless Sex If HIV+ Partner On Suppressive ART: PARTNER Study" by Alison Rodger of Research Department of Infection & Population Health, University College London, London, United Kingdom 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22073.mp3?mediaType=feedmp3 "Summary" by Renate R. Köenig of Paul-Ehrlich-Institut, Langen, Germany http://www.croiwebcasts.org/console/player/22073.mp3 Oral Abstract: Host Factors and HIV/SIV Replication "Summary" by Renate R. Köenig of Paul-Ehrlich-Institut, Langen, Germany 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22075.mp3?mediaType=feedmp3 "Inhibition of Cul4A Neddylation Causes a Reversible Block To SAMHD1-Mediated Restriction of HIV-1" by Henning Hofmann of NYU School of Medicine, New York, NY, United States http://www.croiwebcasts.org/console/player/22075.mp3 Oral Abstract: Host Factors and HIV/SIV Replication "Inhibition of Cul4A Neddylation Causes a Reversible Block To SAMHD1-Mediated Restriction of HIV-1" by Henning Hofmann of NYU School of Medicine, New York, NY, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22076.mp3?mediaType=feedmp3 "MX2, an Interferon-Induced Inhibitor of HIV-1 Infection" by Melissa Kane of The Rockefeller University, New York, NY, United States http://www.croiwebcasts.org/console/player/22076.mp3 Oral Abstract: Host Factors and HIV/SIV Replication "MX2, an Interferon-Induced Inhibitor of HIV-1 Infection" by Melissa Kane of The Rockefeller University, New York, NY, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22077.mp3?mediaType=feedmp3 "BCA2/Rabring7 Targets HIV-1 Gag for Lysosomal Degradation in a Tetherin-Independent Manner" by Ruth Serra-Moreno of Harvard Medical School, Southborough, MA, United States http://www.croiwebcasts.org/console/player/22077.mp3 Oral Abstract: Host Factors and HIV/SIV Replication "BCA2/Rabring7 Targets HIV-1 Gag for Lysosomal Degradation in a Tetherin-Independent Manner" by Ruth Serra-Moreno of Harvard Medical School, Southborough, MA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22078.mp3?mediaType=feedmp3 "Crystal Structure of APOBEC3F Elucidates HIV-1 Vif Interaction and Dynamic Oligomerization" by Markus-Frederik Bohn of Biochemistry, UMass Medical School, Worcester, MA, United States http://www.croiwebcasts.org/console/player/22078.mp3 Oral Abstract: Host Factors and HIV/SIV Replication "Crystal Structure of APOBEC3F Elucidates HIV-1 Vif Interaction and Dynamic Oligomerization" by Markus-Frederik Bohn of Biochemistry, UMass Medical School, Worcester, MA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22079.mp3?mediaType=feedmp3 "Crystal Structure of a TRIM Coiled-Coil: Implications for HIV-1 Capsid Recognition by TRIM5α" by Owen Pornillos of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, United States http://www.croiwebcasts.org/console/player/22079.mp3 Oral Abstract: Host Factors and HIV/SIV Replication "Crystal Structure of a TRIM Coiled-Coil: Implications for HIV-1 Capsid Recognition by TRIM5α" by Owen Pornillos of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22080.mp3?mediaType=feedmp3 "Global Identification of the RNA Targets of HIV-1 Gag During Particle Genesis" by Sebla B. Kutluay of Aaron Diamond AIDS Research Center, New York, NY, United States http://www.croiwebcasts.org/console/player/22080.mp3 Oral Abstract: Host Factors and HIV/SIV Replication "Global Identification of the RNA Targets of HIV-1 Gag During Particle Genesis" by Sebla B. Kutluay of Aaron Diamond AIDS Research Center, New York, NY, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22081.mp3?mediaType=feedmp3 "Gorillas Transmitted SIV To Humans: Identification of HIV-1 Group P and O Ancestors" by Mirela D'arc of Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil http://www.croiwebcasts.org/console/player/22081.mp3 Oral Abstract: Host Factors and HIV/SIV Replication "Gorillas Transmitted SIV To Humans: Identification of HIV-1 Group P and O Ancestors" by Mirela D'arc of Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22082.mp3?mediaType=feedmp3 "A Gorilla Reservoir for Human T-lymphotropic Virus Type 4 (HTLV-4)" by Walid Heneine of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States http://www.croiwebcasts.org/console/player/22082.mp3 Oral Abstract: Host Factors and HIV/SIV Replication "A Gorilla Reservoir for Human T-lymphotropic Virus Type 4 (HTLV-4)" by Walid Heneine of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22141.mp3?mediaType=feedmp3 "A 15-Year Review of Maternal Deaths in a Background of Changing HIV Management Guidelines" by Coceka N. Mnyani of Anova Health Institute, Johannesburg, South Africa and University of the Witwatersrand, Johannesburg, South Africa http://www.croiwebcasts.org/console/player/22141.mp3 Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children "A 15-Year Review of Maternal Deaths in a Background of Changing HIV Management Guidelines" by Coceka N. Mnyani of Anova Health Institute, Johannesburg, South Africa and University of the Witwatersrand, Johannesburg, South Africa 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22142.mp3?mediaType=feedmp3 "Incidence and Cofactors of Acute HIV During Pregnancy and Postpartum" by John Kinuthia of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya http://www.croiwebcasts.org/console/player/22142.mp3 Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children "Incidence and Cofactors of Acute HIV During Pregnancy and Postpartum" by John Kinuthia of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22143.mp3?mediaType=feedmp3 "Efficacy and Safety of LPV/r Versus EFV in HIV+ Pregnant and Breast-Feeding Ugandan Women" by Deborah Cohan of OBGYN, University of California San Francisco, San Francisco, CA, United States http://www.croiwebcasts.org/console/player/22143.mp3 Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children "Efficacy and Safety of LPV/r Versus EFV in HIV+ Pregnant and Breast-Feeding Ugandan Women" by Deborah Cohan of OBGYN, University of California San Francisco, San Francisco, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22144.mp3?mediaType=feedmp3 "Infant Lopinavir/r Versus 3TC To Prevent Postnatal HIV-1 Transmission: The ANRS 12174 Trial" by Chipepo Kankasa of Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia http://www.croiwebcasts.org/console/player/22144.mp3 Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children "Infant Lopinavir/r Versus 3TC To Prevent Postnatal HIV-1 Transmission: The ANRS 12174 Trial" by Chipepo Kankasa of Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22145.mp3?mediaType=feedmp3 "Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate" by George K. Siberry of NICHD, Maternal and Pediatric Infectious Disease Branch, NIH, Bethesda, MD, United States http://www.croiwebcasts.org/console/player/22145.mp3 Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children "Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate" by George K. Siberry of NICHD, Maternal and Pediatric Infectious Disease Branch, NIH, Bethesda, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22146.mp3?mediaType=feedmp3 "Virologic Control by 1 Year of Age Significantly Reduces HIV-1 Reservoirs in Perinatal Infection" by Deborah Persaud of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD, United States http://www.croiwebcasts.org/console/player/22146.mp3 Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children "Virologic Control by 1 Year of Age Significantly Reduces HIV-1 Reservoirs in Perinatal Infection" by Deborah Persaud of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22147.mp3?mediaType=feedmp3 "Virologic Efficacy of Efavirenz Maintenance Therapy in Nevirapine Prophylaxis-ExposedChildren" by Ashraf Coovadia of University of the Witwatersrand, Johannesburg, South Africa http://www.croiwebcasts.org/console/player/22147.mp3 Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children "Virologic Efficacy of Efavirenz Maintenance Therapy in Nevirapine Prophylaxis-ExposedChildren" by Ashraf Coovadia of University of the Witwatersrand, Johannesburg, South Africa 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22148.mp3?mediaType=feedmp3 "Final Results of Koncert: A Randomized Noninferiority Trial of QD Vs BD LPV/r Dosing in Children" by Hermione Lyall of Imperial College London, London, United Kingdom http://www.croiwebcasts.org/console/player/22148.mp3 Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children "Final Results of Koncert: A Randomized Noninferiority Trial of QD Vs BD LPV/r Dosing in Children" by Hermione Lyall of Imperial College London, London, United Kingdom 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22149.mp3?mediaType=feedmp3 "Very Early Combination Antiretroviral Therapy in Perinatal HIV Infection: Two Case Studies" by Deborah Persaud of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD, United States http://www.croiwebcasts.org/console/player/22149.mp3 Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children "Very Early Combination Antiretroviral Therapy in Perinatal HIV Infection: Two Case Studies" by Deborah Persaud of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22153.mp3?mediaType=feedmp3 "Pyroptosis Drives Both CD4 T Cell Death and Chronic Inflammation in HIV-Infected Lymphoid Tissues" by Gilad Doitsh of Gladstone Institute of Virology and Immunology, San Francisco, CA, United States http://www.croiwebcasts.org/console/player/22153.mp3 Oral Abstract: HIV/SIV Pathogenesis "Pyroptosis Drives Both CD4 T Cell Death and Chronic Inflammation in HIV-Infected Lymphoid Tissues" by Gilad Doitsh of Gladstone Institute of Virology and Immunology, San Francisco, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22154.mp3?mediaType=feedmp3 "Early ART Initiation Prevents Disruption of the Mucosal Barrier and Subsequent T-Cell Activation" by Alexandra Schuetz of Retrovirology, USAMC-AFRIMS, Bangkok, Thailand http://www.croiwebcasts.org/console/player/22154.mp3 Oral Abstract: HIV/SIV Pathogenesis "Early ART Initiation Prevents Disruption of the Mucosal Barrier and Subsequent T-Cell Activation" by Alexandra Schuetz of Retrovirology, USAMC-AFRIMS, Bangkok, Thailand 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22155.mp3?mediaType=feedmp3 "Characterizing the IFNα Resistance of Transmitted Founder HIV-1" by Shilpa S. Iyer of Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, PA, United States http://www.croiwebcasts.org/console/player/22155.mp3 Oral Abstract: HIV/SIV Pathogenesis "Characterizing the IFNα Resistance of Transmitted Founder HIV-1" by Shilpa S. Iyer of Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, PA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22156.mp3?mediaType=feedmp3 "Identification of IFI16 as HIV Restriction Factor" by Amalio Telenti of University of Lausanne, Lausanne, Switzerland http://www.croiwebcasts.org/console/player/22156.mp3 Oral Abstract: HIV/SIV Pathogenesis "Identification of IFI16 as HIV Restriction Factor" by Amalio Telenti of University of Lausanne, Lausanne, Switzerland 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22157.mp3?mediaType=feedmp3 "Central Memory and Effector Memory CD4 T Cells From HIV Controllers Harbor Distinct HIV Strains" by Eli Boritz of Human Immunology Section, Vaccine Research Center, Bethesda, MD, United States http://www.croiwebcasts.org/console/player/22157.mp3 Oral Abstract: HIV/SIV Pathogenesis "Central Memory and Effector Memory CD4 T Cells From HIV Controllers Harbor Distinct HIV Strains" by Eli Boritz of Human Immunology Section, Vaccine Research Center, Bethesda, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22158.mp3?mediaType=feedmp3 "Accelerated Viral Load Increase and CD4 Decline in HIV-1 Superinfected Women" by Keshet Ronen of Fred Hutchinson Cancer Research Center, Seattle, WA, United States http://www.croiwebcasts.org/console/player/22158.mp3 Oral Abstract: HIV/SIV Pathogenesis "Accelerated Viral Load Increase and CD4 Decline in HIV-1 Superinfected Women" by Keshet Ronen of Fred Hutchinson Cancer Research Center, Seattle, WA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22159.mp3?mediaType=feedmp3 "Selection for Active SAMHD1 Antagonism in Natural Infections of SIVagm" by Chelsea Spragg of Molecular and Cellular Biology, University of Washington, Seattle, WA, United States and Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States http://www.croiwebcasts.org/console/player/22159.mp3 Oral Abstract: HIV/SIV Pathogenesis "Selection for Active SAMHD1 Antagonism in Natural Infections of SIVagm" by Chelsea Spragg of Molecular and Cellular Biology, University of Washington, Seattle, WA, United States and Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22160.mp3?mediaType=feedmp3 "Probiotic and IL-21 Treatment Promotes Th17 Cell Recovery in ARV-Treatment of Pigtail Macaques" by Alexandra M. Ortiz of LMM, NIH, Bethesda, MD, United States http://www.croiwebcasts.org/console/player/22160.mp3 Oral Abstract: HIV/SIV Pathogenesis "Probiotic and IL-21 Treatment Promotes Th17 Cell Recovery in ARV-Treatment of Pigtail Macaques" by Alexandra M. Ortiz of LMM, NIH, Bethesda, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22164.mp3?mediaType=feedmp3 "First-Line RAL + DRV/r Is Non-Inferior To TDF/FTC + DRV/r: The NEAT001/ANRS143 Randomised Trial" by François Raffi of University Hospital, Nantes, France http://www.croiwebcasts.org/console/player/22164.mp3 Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance "First-Line RAL + DRV/r Is Non-Inferior To TDF/FTC + DRV/r: The NEAT001/ANRS143 Randomised Trial" by François Raffi of University Hospital, Nantes, France 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22165.mp3?mediaType=feedmp3 "Efficacy and Tolerability of Atazanavir, Raltegravir, or Darunavir With FTC/Tenofovir: ACTG 5257" by Raphael J. Landovitz of Center for Clinical AIDS Research & Education, University of California Los Angeles, Los Angeles, CA, United States http://www.croiwebcasts.org/console/player/22165.mp3 Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance "Efficacy and Tolerability of Atazanavir, Raltegravir, or Darunavir With FTC/Tenofovir: ACTG 5257" by Raphael J. Landovitz of Center for Clinical AIDS Research & Education, University of California Los Angeles, Los Angeles, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22166.mp3?mediaType=feedmp3 "Attachment Inhibitor Prodrug BMS-663068 in ARV-Experienced Subjects: Week 24 Analysis" by Jacob Lalezari of Quest Clinical Research, San Francisco, CA, United States http://www.croiwebcasts.org/console/player/22166.mp3 Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance "Attachment Inhibitor Prodrug BMS-663068 in ARV-Experienced Subjects: Week 24 Analysis" by Jacob Lalezari of Quest Clinical Research, San Francisco, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22167.mp3?mediaType=feedmp3 "Sensitive Screening Reveals Widespread Underestimation of Transmitted HIV Drug Resistance" by Jeffrey A. Johnson of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States http://www.croiwebcasts.org/console/player/22167.mp3 Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance "Sensitive Screening Reveals Widespread Underestimation of Transmitted HIV Drug Resistance" by Jeffrey A. Johnson of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22168.mp3?mediaType=feedmp3 "Transmitted HIV-1 Drug Resistance Between Partner-Pairs" by Lisa M. Frenkel of University of Washington, Seattle, WA, United States and Seattle Children's Hospital, Seattle, WA, United States http://www.croiwebcasts.org/console/player/22168.mp3 Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance "Transmitted HIV-1 Drug Resistance Between Partner-Pairs" by Lisa M. Frenkel of University of Washington, Seattle, WA, United States and Seattle Children's Hospital, Seattle, WA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22169.mp3?mediaType=feedmp3 "Silent Mutations in HIV-1 Subtype B Reverse Transcriptase Selected by ART Restore Viral Fitness" by Sushama Telwatte of Centre for Biomedical Research, Burnet Institute, Melbourne, Australia and Department of Microbiology, Monash University, Melbourne, Australia http://www.croiwebcasts.org/console/player/22169.mp3 Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance "Silent Mutations in HIV-1 Subtype B Reverse Transcriptase Selected by ART Restore Viral Fitness" by Sushama Telwatte of Centre for Biomedical Research, Burnet Institute, Melbourne, Australia and Department of Microbiology, Monash University, Melbourne, Australia 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22170.mp3?mediaType=feedmp3 "Reduced In Vivo Replicative Capacity of Drug-Resistant SHIV During Acute Infection" by J. Gerardo Garcia-Lerma of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States http://www.croiwebcasts.org/console/player/22170.mp3 Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance "Reduced In Vivo Replicative Capacity of Drug-Resistant SHIV During Acute Infection" by J. Gerardo Garcia-Lerma of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22171.mp3?mediaType=feedmp3 "744 and Rilpivirine as Two-Drug Oral Maintenance Therapy: LAI116482 (LATTE) Week 48 Results" by David Margolis of GSK, RTP, NC, United States http://www.croiwebcasts.org/console/player/22171.mp3 Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance "744 and Rilpivirine as Two-Drug Oral Maintenance Therapy: LAI116482 (LATTE) Week 48 Results" by David Margolis of GSK, RTP, NC, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22172.mp3?mediaType=feedmp3 "Safety and Antiviral Effect of MK-1439, A Novel NNRTI (+FTC/TDF) in ART-Naive HIV-Infected Patients" by Javier O. Morales-Ramirez of Clinical Research Puerto Rico, San Juan, Puerto Rico http://www.croiwebcasts.org/console/player/22172.mp3 Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance "Safety and Antiviral Effect of MK-1439, A Novel NNRTI (+FTC/TDF) in ART-Naive HIV-Infected Patients" by Javier O. Morales-Ramirez of Clinical Research Puerto Rico, San Juan, Puerto Rico 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22176.mp3?mediaType=feedmp3 "A Phase 2 Trial of a Rifapentine Plus Moxifloxacin-Based Regimen for Pulmonary TB Treatment" by Susan E. Dorman of The Johns Hopkins University School of Medicine, Baltimore, MD, United States http://www.croiwebcasts.org/console/player/22176.mp3 Oral Abstract: TB and Other Coinfections "A Phase 2 Trial of a Rifapentine Plus Moxifloxacin-Based Regimen for Pulmonary TB Treatment" by Susan E. Dorman of The Johns Hopkins University School of Medicine, Baltimore, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22177.mp3?mediaType=feedmp3 "Tuberculosis Infection in Early Childhood in Uganda and the Influence of HIV Exposure" by Carina Marquez of University of California, San Francisco, San Francisco, CA, United States http://www.croiwebcasts.org/console/player/22177.mp3 Oral Abstract: TB and Other Coinfections "Tuberculosis Infection in Early Childhood in Uganda and the Influence of HIV Exposure" by Carina Marquez of University of California, San Francisco, San Francisco, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22178.mp3?mediaType=feedmp3 "Effect of Xpert MTB/RIF On Early Mortality in Adults With Suspected TB: A Pragmatic Randomized Trial" by Gavin Churchyard of Aurum Institute, Houghton, South Africa "Xpert as the First-Line TB Test in South Africa: Yield, Initial Loss To Follow-Up, Proportion Treated" by Katherine L. Fielding of London School of Hygiene & Tropical Medicine, London, United Kingdom http://www.croiwebcasts.org/console/player/22178.mp3 Oral Abstract: TB and Other Coinfections "Effect of Xpert MTB/RIF On Early Mortality in Adults With Suspected TB: A Pragmatic Randomized Trial" by Gavin Churchyard of Aurum Institute, Houghton, South Africa "Xpert as the First-Line TB Test in South Africa: Yield, Initial Loss To Follow-Up, Proportion Treated" by Katherine L. Fielding of London School of Hygiene & Tropical Medicine, London, United Kingdom 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22180.mp3?mediaType=feedmp3 "14 Day EBA Study of PA-824, Bedaquiline, Pyrazinamide and Clofazimine in Smear-Positive TB Patients" by Andreas Diacon of Department of Medical Biochemistry, Stellenbosch University, Cape Town, South Africa http://www.croiwebcasts.org/console/player/22180.mp3 Oral Abstract: TB and Other Coinfections "14 Day EBA Study of PA-824, Bedaquiline, Pyrazinamide and Clofazimine in Smear-Positive TB Patients" by Andreas Diacon of Department of Medical Biochemistry, Stellenbosch University, Cape Town, South Africa 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22181.mp3?mediaType=feedmp3 "CTX Prophylaxis Discontinuation Among ART-Treated Adults: A Randomized Non-Inferiority Trial" by Christina S. Polyak of Military HIV Research Program, Walter Reed Army Institute of Research, University of Washington, Bethesda, MD, United States http://www.croiwebcasts.org/console/player/22181.mp3 Oral Abstract: TB and Other Coinfections "CTX Prophylaxis Discontinuation Among ART-Treated Adults: A Randomized Non-Inferiority Trial" by Christina S. Polyak of Military HIV Research Program, Walter Reed Army Institute of Research, University of Washington, Bethesda, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22230.mp3?mediaType=feedmp3 "HIV and Elevated Cancer-Specific Mortality Following Cancer Diagnosis in the United States" by Anna E. Coghill of Division of Cancer Epidemiology and Genetics, National Cancer Institute, Washington, DC, United States http://www.croiwebcasts.org/console/player/22230.mp3 Oral Abstract: Malignancies and Pharmacology "HIV and Elevated Cancer-Specific Mortality Following Cancer Diagnosis in the United States" by Anna E. Coghill of Division of Cancer Epidemiology and Genetics, National Cancer Institute, Washington, DC, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22231.mp3?mediaType=feedmp3 "Impact of Kaposi Sarcoma On Survival in HIV-Infected African Adults On Antiretroviral Therapy" by Stephen B. Asiimwe of Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, United States and Department of Internal Medicine, Mbarara Regional Referral Hospital, Mbarara, Uganda http://www.croiwebcasts.org/console/player/22231.mp3 Oral Abstract: Malignancies and Pharmacology "Impact of Kaposi Sarcoma On Survival in HIV-Infected African Adults On Antiretroviral Therapy" by Stephen B. Asiimwe of Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, United States and Department of Internal Medicine, Mbarara Regional Referral Hospital, Mbarara, Uganda 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22232.mp3?mediaType=feedmp3 "Prospective Characterization of Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome" by Mark N. Polizzotto of HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, United States http://www.croiwebcasts.org/console/player/22232.mp3 Oral Abstract: Malignancies and Pharmacology "Prospective Characterization of Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome" by Mark N. Polizzotto of HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22233.mp3?mediaType=feedmp3 "Quadrivalent HPV Vaccine Demonstrates Immune Memory in HIV-1-Infected Men" by Timothy Wilkin of Division of Infectious Diseases, Weill Cornell Medical College, New York, NY, United States http://www.croiwebcasts.org/console/player/22233.mp3 Oral Abstract: Malignancies and Pharmacology "Quadrivalent HPV Vaccine Demonstrates Immune Memory in HIV-1-Infected Men" by Timothy Wilkin of Division of Infectious Diseases, Weill Cornell Medical College, New York, NY, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22234.mp3?mediaType=feedmp3 "HIV-1 Infection Alters Intestinal Expression of Antiretroviral Drug Transporters and Enzymes" by Reina Bendayan of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada http://www.croiwebcasts.org/console/player/22234.mp3 Oral Abstract: Malignancies and Pharmacology "HIV-1 Infection Alters Intestinal Expression of Antiretroviral Drug Transporters and Enzymes" by Reina Bendayan of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22235.mp3?mediaType=feedmp3 "Tenofovir-Emtricitabine Directly Observed Dosing: 100% Adherence Concentrations (HPTN 066)" by Craig W. Hendrix of The Johns Hopkins University, Baltimore, MD, United States http://www.croiwebcasts.org/console/player/22235.mp3 Oral Abstract: Malignancies and Pharmacology "Tenofovir-Emtricitabine Directly Observed Dosing: 100% Adherence Concentrations (HPTN 066)" by Craig W. Hendrix of The Johns Hopkins University, Baltimore, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22236.mp3?mediaType=feedmp3 "Efavirenz Pharmacokinetics in HIV+ Persons Receiving Rifapentine and Isoniazid for TB Prevention" by Anthony T. Podany of College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, United States http://www.croiwebcasts.org/console/player/22236.mp3 Oral Abstract: Malignancies and Pharmacology "Efavirenz Pharmacokinetics in HIV+ Persons Receiving Rifapentine and Isoniazid for TB Prevention" by Anthony T. Podany of College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22237.mp3?mediaType=feedmp3 "Pharmacokinetic Variability in TB Therapy: Associations With HIV and Effect On Outcome" by Derek J. Sloan of Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi http://www.croiwebcasts.org/console/player/22237.mp3 Oral Abstract: Malignancies and Pharmacology "Pharmacokinetic Variability in TB Therapy: Associations With HIV and Effect On Outcome" by Derek J. Sloan of Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22264.mp3?mediaType=feedmp3 "Increased Arterial Inflammation Relates to High-Risk Coronary Plaque Morphology in HIV+ Patients" by Markella V. Zanni of Program in Nutritional Metabolism, Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States http://www.croiwebcasts.org/console/player/22264.mp3 Oral Abstract: CV and Other Complications "Increased Arterial Inflammation Relates to High-Risk Coronary Plaque Morphology in HIV+ Patients" by Markella V. Zanni of Program in Nutritional Metabolism, Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22265.mp3?mediaType=feedmp3 "Arterial Inflammation in HIV as Measured by FDG-PET/CT Is Associated With Splenic Activity" by Priscilla Y. Hsue of Cardiology, University of California San Francisco, San Francisco, CA, United States http://www.croiwebcasts.org/console/player/22265.mp3 Oral Abstract: CV and Other Complications "Arterial Inflammation in HIV as Measured by FDG-PET/CT Is Associated With Splenic Activity" by Priscilla Y. Hsue of Cardiology, University of California San Francisco, San Francisco, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22266.mp3?mediaType=feedmp3 "Replicative Senescence of Circulating Osteogenic Cells and Low BMD in Perinatally Infected Men" by Michael T. Yin of Columbia University Medical Center, New York, NY, United States http://www.croiwebcasts.org/console/player/22266.mp3 Oral Abstract: CV and Other Complications "Replicative Senescence of Circulating Osteogenic Cells and Low BMD in Perinatally Infected Men" by Michael T. Yin of Columbia University Medical Center, New York, NY, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22267.mp3?mediaType=feedmp3 "High-Dose Vitamin D and Calcium Attenuates Bone Loss With ART Initiation: Results From ACTG A5280" by Edgar T. Overton of University of Alabama School of Medicine, Birmingham, AL, United States http://www.croiwebcasts.org/console/player/22267.mp3 Oral Abstract: CV and Other Complications "High-Dose Vitamin D and Calcium Attenuates Bone Loss With ART Initiation: Results From ACTG A5280" by Edgar T. Overton of University of Alabama School of Medicine, Birmingham, AL, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22268.mp3?mediaType=feedmp3 "Rosuvastatin Improves Hip Bone Mineral Density But Worsens Insulin Resistance" by Grace A. McComsey of Case Western Reserve University, Cleveland, OH, United States http://www.croiwebcasts.org/console/player/22268.mp3 Oral Abstract: CV and Other Complications "Rosuvastatin Improves Hip Bone Mineral Density But Worsens Insulin Resistance" by Grace A. McComsey of Case Western Reserve University, Cleveland, OH, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22269.mp3?mediaType=feedmp3 "Effects of Tesamorelin On Hepatic Fat in HIV Patients: A Randomized, Placebo-Controlled Trial" by Steven Grinspoon of Massachusetts General Hospital, Boston, MA, United States http://www.croiwebcasts.org/console/player/22269.mp3 Oral Abstract: CV and Other Complications "Effects of Tesamorelin On Hepatic Fat in HIV Patients: A Randomized, Placebo-Controlled Trial" by Steven Grinspoon of Massachusetts General Hospital, Boston, MA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22272.mp3?mediaType=feedmp3 "Moderator" by Mary Kearney of National Cancer Institute, Frederick, MD, United States http://www.croiwebcasts.org/console/player/22272.mp3 Oral Abstract: Persistence "Moderator" by Mary Kearney of National Cancer Institute, Frederick, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22273.mp3?mediaType=feedmp3 "Early Treatment in Acute SIV Infection Limits the Size and Distribution of the Viral Reservoir" by Afam A. Okoye of Vaccine & Gene Therapy Institute and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States http://www.croiwebcasts.org/console/player/22273.mp3 Oral Abstract: Persistence "Early Treatment in Acute SIV Infection Limits the Size and Distribution of the Viral Reservoir" by Afam A. Okoye of Vaccine & Gene Therapy Institute and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22274.mp3?mediaType=feedmp3 "CD4 T-Cell Subset Composition of HIV Reservoirs in Gut, Lymphnode, and Blood During HAART" by Joseph K. Wong of University of California San Francisco, San Francisco, CA, United States and San Francisco Veterans Affairs Medical Center, San Francisco, CA, United States http://www.croiwebcasts.org/console/player/22274.mp3 Oral Abstract: Persistence "CD4 T-Cell Subset Composition of HIV Reservoirs in Gut, Lymphnode, and Blood During HAART" by Joseph K. Wong of University of California San Francisco, San Francisco, CA, United States and San Francisco Veterans Affairs Medical Center, San Francisco, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22275.mp3?mediaType=feedmp3 "Proliferation of Cells With HIV Integrated Into Regulatory Genes Is a Mechanism of Persistence" by Thor A. Wagner of University of Washington, Seattle, WA, United States and Seattle Children’s Hospital, Seattle, WA, United States http://www.croiwebcasts.org/console/player/22275.mp3 Oral Abstract: Persistence "Proliferation of Cells With HIV Integrated Into Regulatory Genes Is a Mechanism of Persistence" by Thor A. Wagner of University of Washington, Seattle, WA, United States and Seattle Children’s Hospital, Seattle, WA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22276.mp3?mediaType=feedmp3 "Novel Ex Vivo Approaches Distinguish Effective and Ineffective Drugs for Reversing Latency In Vivo" by Gregory M. Laird of The Johns Hopkins University School of Medicine, Baltimore, MD, United States http://www.croiwebcasts.org/console/player/22276.mp3 Oral Abstract: Persistence "Novel Ex Vivo Approaches Distinguish Effective and Ineffective Drugs for Reversing Latency In Vivo" by Gregory M. Laird of The Johns Hopkins University School of Medicine, Baltimore, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22277.mp3?mediaType=feedmp3 "Effect of Vorinostat On Host Gene Expression in HIV Infected Patients On Antiretroviral Therapy" by Khader Ghneim of VGTI-FL, Port Saint Lucie, FL, United States http://www.croiwebcasts.org/console/player/22277.mp3 Oral Abstract: Persistence "Effect of Vorinostat On Host Gene Expression in HIV Infected Patients On Antiretroviral Therapy" by Khader Ghneim of VGTI-FL, Port Saint Lucie, FL, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22278.mp3?mediaType=feedmp3 "Cyclophosphamide Enhances SB-728-T Engraftment To Levels Associated With HIV-RNA Control" by Gary Blick of Circle Care Center, Norwalk, CT, United States http://www.croiwebcasts.org/console/player/22278.mp3 Oral Abstract: Persistence "Cyclophosphamide Enhances SB-728-T Engraftment To Levels Associated With HIV-RNA Control" by Gary Blick of Circle Care Center, Norwalk, CT, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22279.mp3?mediaType=feedmp3 "Stimulation of Subdominant CTL Response Is Required for the Elimination of HIV-1 Latent Reservoir" by Kai Deng of The Johns Hopkins University, Baltimore, MD, United States http://www.croiwebcasts.org/console/player/22279.mp3 Oral Abstract: Persistence "Stimulation of Subdominant CTL Response Is Required for the Elimination of HIV-1 Latent Reservoir" by Kai Deng of The Johns Hopkins University, Baltimore, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22280.mp3?mediaType=feedmp3 "Dendritic Cell-Based HIV Therapeutic Vaccine Increases Residual Viremia in Individuals On ART" by Bernard J. Macatangay of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States http://www.croiwebcasts.org/console/player/22280.mp3 Oral Abstract: Persistence "Dendritic Cell-Based HIV Therapeutic Vaccine Increases Residual Viremia in Individuals On ART" by Bernard J. Macatangay of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22281.mp3?mediaType=feedmp3 "HIV-1 Rebound Following Allogeneic Stem Cell Transplantation and Treatment Interruption" by Timothy J. Henrich of Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, United States http://www.croiwebcasts.org/console/player/22281.mp3 Oral Abstract: Persistence "HIV-1 Rebound Following Allogeneic Stem Cell Transplantation and Treatment Interruption" by Timothy J. Henrich of Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22285.mp3?mediaType=feedmp3 "Age-Disparate Relationships and HIV Incidence Amongst Rural South Africa Women" by Guy Harling of Global Health and Population, Harvard School of Public Health, Boston, MA, United States http://www.croiwebcasts.org/console/player/22285.mp3 Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities "Age-Disparate Relationships and HIV Incidence Amongst Rural South Africa Women" by Guy Harling of Global Health and Population, Harvard School of Public Health, Boston, MA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22286.mp3?mediaType=feedmp3 "Introduction of HIV into Stable Heterosexual Couples in Rakai, Uganda Before and After ART" by Mary K. Grabowski of Epidemiology, The Johns Hopkins University, Baltimore, MD, United States http://www.croiwebcasts.org/console/player/22286.mp3 Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities "Introduction of HIV into Stable Heterosexual Couples in Rakai, Uganda Before and After ART" by Mary K. Grabowski of Epidemiology, The Johns Hopkins University, Baltimore, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22287.mp3?mediaType=feedmp3 "One Year Outcomes Following Community-Based HIV Self-Testing: A Prospective Study in Malawi" by Augustine T. Choko of Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi http://www.croiwebcasts.org/console/player/22287.mp3 Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities "One Year Outcomes Following Community-Based HIV Self-Testing: A Prospective Study in Malawi" by Augustine T. Choko of Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22288.mp3?mediaType=feedmp3 "Community HIV Testing and Linkage To Care Reduces Population Viral Load in South Africa and Uganda" by Ruanne V. Barnabas of Global Health and Medicine, University of Washington, Seattle, WA, United States and Fred Hutchinson Cancer Research Center, Seattle, WA, United States http://www.croiwebcasts.org/console/player/22288.mp3 Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities "Community HIV Testing and Linkage To Care Reduces Population Viral Load in South Africa and Uganda" by Ruanne V. Barnabas of Global Health and Medicine, University of Washington, Seattle, WA, United States and Fred Hutchinson Cancer Research Center, Seattle, WA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22289.mp3?mediaType=feedmp3 "Enhanced HIV Surveillance To Evaluate the National Response To HIV/AIDS in Kenya" by William Maina of National AIDS and STI Control Programme, Ministry of Health, Nairobi, Kenya http://www.croiwebcasts.org/console/player/22289.mp3 Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities "Enhanced HIV Surveillance To Evaluate the National Response To HIV/AIDS in Kenya" by William Maina of National AIDS and STI Control Programme, Ministry of Health, Nairobi, Kenya 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22290.mp3?mediaType=feedmp3 "Unequal Benefits From ART: A Growing Male Disadvantage in Life Expectancy in Rural South Africa" by Till Barnighausen of Global Health and Population, Harvard School of Public Health, Boston, MA, United States and Africa Centre for Health and Population Studies, Mtubatuba, South Africa http://www.croiwebcasts.org/console/player/22290.mp3 Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities "Unequal Benefits From ART: A Growing Male Disadvantage in Life Expectancy in Rural South Africa" by Till Barnighausen of Global Health and Population, Harvard School of Public Health, Boston, MA, United States and Africa Centre for Health and Population Studies, Mtubatuba, South Africa 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22291.mp3?mediaType=feedmp3 "A New Paradigm for Evaluating the HIV Care Cascade" by Margaret L. McNairy of ICAP Columbia University, New York, NY, United States http://www.croiwebcasts.org/console/player/22291.mp3 Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities "A New Paradigm for Evaluating the HIV Care Cascade" by Margaret L. McNairy of ICAP Columbia University, New York, NY, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22292.mp3?mediaType=feedmp3 "Moderate HIV Incidence and High ART Coverage in Rural Kwazulu-Natal: First Population-Based Survey" by Helena Huerga of Epicentre, Paris, France http://www.croiwebcasts.org/console/player/22292.mp3 Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities "Moderate HIV Incidence and High ART Coverage in Rural Kwazulu-Natal: First Population-Based Survey" by Helena Huerga of Epicentre, Paris, France 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22297.mp3?mediaType=feedmp3 "Cryo-EM Structures of the HIV-1 Env Trimer Reveal the Full Extent of Neutralizing Antibody Epitopes" by Andrew B. Ward of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, United States http://www.croiwebcasts.org/console/player/22297.mp3 Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV "Cryo-EM Structures of the HIV-1 Env Trimer Reveal the Full Extent of Neutralizing Antibody Epitopes" by Andrew B. Ward of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22298.mp3?mediaType=feedmp3 "Immunogenicity of Cleaved, Soluble BG505 SOSIP.664 Native-Like Trimers in Rabbits" by John P. Moore of Microbiology/Immunology, Weill Medical College, New York, NY, United States http://www.croiwebcasts.org/console/player/22298.mp3 Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV "Immunogenicity of Cleaved, Soluble BG505 SOSIP.664 Native-Like Trimers in Rabbits" by John P. Moore of Microbiology/Immunology, Weill Medical College, New York, NY, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22299.mp3?mediaType=feedmp3 "Identification of a New Neutralization Target at the N262/N448 Glycosylation Sites On HIV-1 gp120" by Xueling Wu of Aaron Diamond AIDS Research Center, New York, NY, United States http://www.croiwebcasts.org/console/player/22299.mp3 Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV "Identification of a New Neutralization Target at the N262/N448 Glycosylation Sites On HIV-1 gp120" by Xueling Wu of Aaron Diamond AIDS Research Center, New York, NY, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22300.mp3?mediaType=feedmp3 "CD169 Mediates HIV-1 Evasion From Detection by α-gp120 Neutralizing Antibodies in Dendritic Cells" by Hisashi Akiyama of Microbiology, Boston University School of Medicine, Boston, MA, United States http://www.croiwebcasts.org/console/player/22300.mp3 Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV "CD169 Mediates HIV-1 Evasion From Detection by α-gp120 Neutralizing Antibodies in Dendritic Cells" by Hisashi Akiyama of Microbiology, Boston University School of Medicine, Boston, MA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22301.mp3?mediaType=feedmp3 "Tetherin Antagonism by Vpu Protects HIV-Infected Cells From ADCC" by Juan F. Arias of Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, United States http://www.croiwebcasts.org/console/player/22301.mp3 Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV "Tetherin Antagonism by Vpu Protects HIV-Infected Cells From ADCC" by Juan F. Arias of Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22302.mp3?mediaType=feedmp3 "HIV Nef and Vpu Protect HIV-infected CD4+ T Cells From ADCC Through Downmodulation of CD4 and BST2" by Tram N. Q. Pham of Institut de Recherches Cliniques de Montréal, Montreal, QC, Canada http://www.croiwebcasts.org/console/player/22302.mp3 Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV "HIV Nef and Vpu Protect HIV-infected CD4+ T Cells From ADCC Through Downmodulation of CD4 and BST2" by Tram N. Q. Pham of Institut de Recherches Cliniques de Montréal, Montreal, QC, Canada 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22303.mp3?mediaType=feedmp3 "Identification of HIV-infected CD4+ T Cells Using HIV RNA and Broadly Neutralizing Antibodies" by Joseph P. Casazza of Immunology Laboratory, NIAID, Bethesda, MD, United States http://www.croiwebcasts.org/console/player/22303.mp3 Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV "Identification of HIV-infected CD4+ T Cells Using HIV RNA and Broadly Neutralizing Antibodies" by Joseph P. Casazza of Immunology Laboratory, NIAID, Bethesda, MD, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22304.mp3?mediaType=feedmp3 "Type I Interferon Signaling Is Critical for Early Control of Immune System Damage" by Netanya G. Sandler of Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, TX, United States http://www.croiwebcasts.org/console/player/22304.mp3 Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV "Type I Interferon Signaling Is Critical for Early Control of Immune System Damage" by Netanya G. Sandler of Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, TX, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/22305.mp3?mediaType=feedmp3 "miR-422a: A Solitary MicroRNA Biomarker of Interferon-α Anti-HIV-1 Activity In Vivo" by Mohamed Abdel-Mohsen of Medicine, University of California, San Francisco, San Francisco, CA, United States and Blood Systems Research Institute, San Francisco, CA, United States http://www.croiwebcasts.org/console/player/22305.mp3 Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV "miR-422a: A Solitary MicroRNA Biomarker of Interferon-α Anti-HIV-1 Activity In Vivo" by Mohamed Abdel-Mohsen of Medicine, University of California, San Francisco, San Francisco, CA, United States and Blood Systems Research Institute, San Francisco, CA, United States 00:00:00.0 Podcasts Podcasts